These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25837442)

  • 1. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
    Curis E; Pestre V; Jullien V; Eyrolle L; Archambeau D; Morand P; Gatin L; Karoubi M; Pinar N; Dumaine V; Nguyen Van JC; Babinet A; Anract P; Salmon D
    Infection; 2015 Aug; 43(4):473-81. PubMed ID: 25837442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone and joint infections: Risk of clindamycin low concentration when combined with rifampicin].
    Groupe bibliographique de la SPILF
    Med Mal Infect; 2015 Aug; 45(8):343. PubMed ID: 26716141
    [No Abstract]   [Full Text] [Related]  

  • 3. Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination.
    Bernard A; Kermarrec G; Parize P; Caruba T; Bouvet A; Mainardi JL; Sabatier B; Nich C
    J Infect; 2015 Aug; 71(2):200-6. PubMed ID: 25936632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.
    Bonnaire A; Vernet-Garnier V; Lebrun D; Bajolet O; Bonnet M; Hentzien M; Ohl X; Diallo S; Bani-Sadr F
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115225. PubMed ID: 33099073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
    Goulenok T; Seurat J; Selle A; Jullien V; Leflon-Guibout V; Grall N; Lescure FX; Lepeule R; Bertrand J; Fantin B; Burdet C; Lefort A
    Int J Antimicrob Agents; 2023 Aug; 62(2):106885. PubMed ID: 37302771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections.
    Roblot F; Besnier JM; Giraudeau B; Simonnard N; Jonville-Bera AP; Coipeau P; Choutet P; Autret-Leca E; Le Guellec C
    Fundam Clin Pharmacol; 2007 Aug; 21(4):363-9. PubMed ID: 17635174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.
    Nguyen S; Pasquet A; Legout L; Beltrand E; Dubreuil L; Migaud H; Yazdanpanah Y; Senneville E
    Clin Microbiol Infect; 2009 Dec; 15(12):1163-9. PubMed ID: 19438638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.
    Zeller V; Dzeing-Ella A; Kitzis MD; Ziza JM; Mamoudy P; Desplaces N
    Antimicrob Agents Chemother; 2010 Jan; 54(1):88-92. PubMed ID: 19841148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.
    O'Reilly T; Kunz S; Sande E; Zak O; Sande MA; Täuber MG
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2693-7. PubMed ID: 1336342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
    Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
    Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.
    Bouazza N; Pestre V; Jullien V; Curis E; Urien S; Salmon D; Tréluyer JM
    Br J Clin Pharmacol; 2012 Dec; 74(6):971-7. PubMed ID: 22486719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.
    Join-Lambert O; Ribadeau-Dumas F; Jullien V; Kitzis MD; Jais JP; Coignard-Biehler H; Guet-Revillet H; Consigny PH; Delage M; Nassif X; Lortholary O; Nassif A
    Eur J Dermatol; 2014; 24(1):94-5. PubMed ID: 24445967
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
    Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP
    Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
    Viale P; Furlanut M; Scudeller L; Pavan F; Negri C; Crapis M; Zamparini E; Zuiani C; Cristini F; Pea F
    Int J Antimicrob Agents; 2009 Apr; 33(4):379-82. PubMed ID: 19097864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
    Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
    Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the clindamycin administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic study.
    Zeller V; Magreault S; Heym B; Salmon D; Kitzis MD; Billaud E; Marmor S; Jannot AS; Salomon L; Jullien V
    Clin Microbiol Infect; 2021 Dec; 27(12):1857.e1-1857.e7. PubMed ID: 33915288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
    Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
    Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].
    Sánchez C; Matamala A; Salavert M; Cuchí E; Pons M; Anglés F; Garau J
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):10-3. PubMed ID: 9147500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections.
    Czekaj J; Dinh A; Moldovan A; Vaudaux P; Gras G; Hoffmeyer P; Lew D; Bernard L; Uçkay I
    Scand J Infect Dis; 2011 Dec; 43(11-12):962-7. PubMed ID: 21916775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.